Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Soleil Boughton sold 2,343 shares of Hims & Hers Health stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $29.90, for a total value of $70,055.70. Following the completion of the transaction, the insider now directly owns 165,254 shares in the company, valued at $4,941,094.60. This trade represents a 1.40 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Soleil Boughton also recently made the following trade(s):
- On Tuesday, October 29th, Soleil Boughton sold 2,339 shares of Hims & Hers Health stock. The stock was sold at an average price of $23.16, for a total value of $54,171.24.
- On Tuesday, October 15th, Soleil Boughton sold 2,339 shares of Hims & Hers Health stock. The shares were sold at an average price of $20.41, for a total value of $47,738.99.
- On Tuesday, September 17th, Soleil Boughton sold 2,339 shares of Hims & Hers Health stock. The shares were sold at an average price of $16.50, for a total value of $38,593.50.
- On Tuesday, September 3rd, Soleil Boughton sold 2,345 shares of Hims & Hers Health stock. The shares were sold at an average price of $14.65, for a total value of $34,354.25.
Hims & Hers Health Stock Down 2.2 %
Massive shakeup in defense contracting
From DTI | Ad
There is a little-known energy technology stock that has made an incredible breakthrough…
Which could become crucial to the operations of the US Military.
And right now there are plans for this stock to undertake a major test project at a US Air Force based in Alaska.
Now, this incredible breakthrough is still in its earliest stages…
Which means you still have a chance to get in while its trading for under $10.
You need to check out the full story right here.
Shares of HIMS opened at $30.67 on Wednesday. The business has a 50-day simple moving average of $20.85 and a two-hundred day simple moving average of $19.44. The stock has a market cap of $6.70 billion, a price-to-earnings ratio of 69.69 and a beta of 1.06. Hims & Hers Health, Inc. has a 52 week low of $8.09 and a 52 week high of $31.68.
Hims & Hers Health (NYSE:HIMS - Get Free Report) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.32 EPS for the quarter, topping analysts' consensus estimates of $0.06 by $0.26. Hims & Hers Health had a return on equity of 10.97% and a net margin of 8.19%. The business had revenue of $401.56 million during the quarter, compared to analysts' expectations of $382.20 million. During the same quarter in the prior year, the business posted ($0.04) earnings per share. The business's quarterly revenue was up 77.1% on a year-over-year basis. On average, equities analysts anticipate that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current fiscal year.
Institutional Trading of Hims & Hers Health
Several institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. grew its position in shares of Hims & Hers Health by 1.0% during the first quarter. Vanguard Group Inc. now owns 14,310,192 shares of the company's stock worth $221,379,000 after purchasing an additional 136,907 shares in the last quarter. Renaissance Technologies LLC grew its position in shares of Hims & Hers Health by 113.1% during the second quarter. Renaissance Technologies LLC now owns 6,039,408 shares of the company's stock worth $121,936,000 after purchasing an additional 3,205,108 shares in the last quarter. State Street Corp grew its position in shares of Hims & Hers Health by 4.7% during the third quarter. State Street Corp now owns 4,626,543 shares of the company's stock worth $85,221,000 after purchasing an additional 206,078 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Hims & Hers Health by 12.7% during the third quarter. Geode Capital Management LLC now owns 4,289,549 shares of the company's stock worth $79,029,000 after purchasing an additional 482,177 shares in the last quarter. Finally, Wellington Management Group LLP grew its position in shares of Hims & Hers Health by 34.5% during the third quarter. Wellington Management Group LLP now owns 3,444,414 shares of the company's stock worth $63,446,000 after purchasing an additional 883,230 shares in the last quarter. Hedge funds and other institutional investors own 63.52% of the company's stock.
Analyst Ratings Changes
Several brokerages recently weighed in on HIMS. Canaccord Genuity Group upped their price target on Hims & Hers Health from $24.00 to $28.00 and gave the stock a "buy" rating in a research note on Tuesday, November 5th. Piper Sandler reaffirmed a "neutral" rating and issued a $21.00 price target (up from $18.00) on shares of Hims & Hers Health in a research note on Tuesday, November 5th. Bank of America downgraded Hims & Hers Health from a "buy" rating to an "underperform" rating and dropped their target price for the stock from $32.00 to $18.00 in a report on Thursday, November 14th. Deutsche Bank Aktiengesellschaft boosted their target price on Hims & Hers Health from $23.00 to $27.00 and gave the stock a "hold" rating in a report on Wednesday, November 6th. Finally, Needham & Company LLC began coverage on Hims & Hers Health in a report on Thursday, August 22nd. They set a "buy" rating and a $24.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $20.71.
Read Our Latest Research Report on Hims & Hers Health
About Hims & Hers Health
(
Get Free Report)
Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
